Cargando…
ID1 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Deterioration of Clear Cell Renal Cell Carcinoma
Clear cell renal cell carcinoma (ccRCC) is one of the most common cancers in the world. Our aim is to identify prognostic biomarkers that contribute to the progression of early stage ccRCC and clarify the mechanism. Here, the mRNA microarray expression profile of ccRCC samples was obtained from Gene...
Autores principales: | Qiu, Xiangmin, Gu, Yuping, Ni, Yilu, Li, Qianyin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7647745/ https://www.ncbi.nlm.nih.gov/pubmed/33178820 http://dx.doi.org/10.1155/2020/2064582 |
Ejemplares similares
-
Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm
por: Luo, Jun, et al.
Publicado: (2020) -
IMP3, a Promising Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Park, Ji Young, et al.
Publicado: (2014) -
CASP9 As a Prognostic Biomarker and Promising Drug Target Plays a Pivotal Role in Inflammatory Breast Cancer
por: Zhang, Mingdi, et al.
Publicado: (2022) -
AURKB: a promising biomarker in clear cell renal cell carcinoma
por: Wan, Bangbei, et al.
Publicado: (2019) -
TFE3‐PD‐L1 axis is pivotal for sunitinib resistance in clear cell renal cell carcinoma
por: Guo, Xudong, et al.
Publicado: (2020)